The Ministry of Public Health of the Republic of Lebanon has approved KYMOS as Reference Laboratory for Biological Drug Tests. This is an important acknowledgement to the efforts undertaken by KYMOS to develop innovative analytical methods for biosimilars and biotechnological products.

KYMOS has experience in method development, validation and testing of different biosimilars like infliximab, trastuzumab, pelgastrim or omalizumab; polisaccharides as heparins; immunoglobulins; insulines; and innovative antibody drug conjugates.

Click here: List_of_Reference_Labs_in_Lebanon.pdf

Documents & Resources

careers-header

Access essential Documents & Resources to stay informed and up to date.

Fased Bio Advances Publication
Research Article

Validation of extracellular miRNA quantification in blood samples using RT-qPCR